Tether acquires a majority stake in Blackrock Neurotech for $200M

Blackrock Neurotech/Utah array / NeuroPort

Stablecoin issuer Tether invested $200M in Blackrock Neurotech through its newly created venture arm Tether Evo, becoming the company's majority stakeholder. The capital funds commercialization of the Utah array brain-computer interface electrodes used in many academic BCI studies and supports broader research and development initiatives.

• Investment made from Tether company profits ($2.9B net profit Q4 2023), not stablecoin reserves; Tether Evo's inaugural venture investment.
• Blackrock Neurotech develops BCI technology for paralysis and neurological disorders; Utah arrays widely used in research; investment accelerates commercialization.
• Founded 2008, Salt Lake City; previous notable use: 2016 demonstration where Nathan Copeland used implant to greet President Obama via robotic arm control.